Timothy Caulfield, JD, discusses the sessions he's most looking forward to at this year's Society for Pediatric Dermatology annual meeting, including his talk on overcoming misinformation in pediatric dermatology.
Timothy Caulfied, JD, professor in the Faculty of Law in the School of Public Health and research director of the Health Law Institute at the University of Alberta, discusses the sessions he's most looking forward to at this year's Society of Pediatric Dermatology (SPD) annual meeting, including his talk on overcoming misinformation in pediatric dermatology.
Transcript
What sessions are you most looking forward to checking out at SPD 2024?
You know, I'm really looking forward to talking to this community. First of all, I think this community is incredibly relevant. I think this is a hot topic for this community, for this audience. So I'm looking forward to engaging with them. And also [I'm] really interested in their thoughts about what kinds of issues in the misinformation sphere they're seeing. But the other reason I'm thrilled to have this opportunity is I think this community can make a real difference. We know that there's been an erosion in trust for institutions generally—for science and, yes, for physicians—but health care providers are still amongst the most trusted voices, especially when you're talking about that physician-patient relationship. So, yeah, [I'm] very excited to talk with this community and looking forward to the event.
What will audiences be able to take away from your presentation on misinformation in the field of pediatric dermatology?
Look, I hope it was obvious that this is a major problem. I think that the spread of health misinformation is one of the greatest challenges of our time, and I really tried to hammer that.
I don't think that's a hard sell for this community but the scope and the breadth of the problem is really tremendous. And so the presentation was a little bit a call to arms, right? You know, we need everyone to step up.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More